Stephen Saad’s stake in Africa’s largest pharmaceutical company sinks below $600 million
South African pharmaceutical tycoon Stephen Saad faces setback as Aspen Pharmacare shares decline.
Related
South African tycoon Stephen Saad’s Aspen stake loses $18 million
Stephen Saad’s Aspen stake drops $18 million as shares fall 5.45% in 16 days, deepening losses for South Africa’s largest drugmaker.
Aspen’s market slide wipes $20 million off Stephen Saad’s stake
Stephen Saad’s Aspen Pharmacare stake drops by $20 million as the company’s stock slips 6 percent on the Johannesburg Stock Exchange (JSE).
South African pharma tycoon Stephen Saad’s Aspen stake tops $340 million
Aspen Pharmacare shares edge higher, boosting CEO Stephen Saad’s holdings above $340 million despite the stock’s 37% year-to-date decline.
South Africa’s Stephen Saad expects $50 million sales from Aspen’s weight loss drug
South African pharma tycoon Stephen Saad says Aspen’s weight loss drug could reach $50 million in sales within two years.
Latest
Ackerman family gives up majority control of Pick n Pay as Allan Gray’s stake grows
Pick n Pay’s founding family falls below 50% control as Allan Gray ups its stake, sharpening focus on the retailer’s troubled turnaround.
Prudential’s exit plan tests Patrice Motsepe’s grip on Alexforbes
Prudential’s possible Alexforbes exit hands Patrice Motsepe a pivotal moment: tighten African Rainbow Capital’s control or share power with a new global investor.
Inside Black Coffee’s empire: 15 businesses and investments owned by the South African DJ
From Soweto venues to Silicon Valley–backed startups and Cape Town’s most expensive house, Black Coffee has turned DJ fees into a serious investment empire.
Flex raises $60 million Series B to build AI “private bank” for high net worth business owners
Flex raises fresh funding to scale its AI-native private bank, targeting high net worth middle-market owners juggling complex business and personal finances.